327 related articles for article (PubMed ID: 26776557)
1. Prognostic value of collagen turnover biomarkers in cardiac resynchronization therapy: A subanalysis of the TRUST CRT randomized trial population.
Sokal A; Lenarczyk R; Kowalski O; Mitrega K; Pluta S; Stabryla-Deska J; Streb W; Urbanik Z; Krzeminski TF; Kalarus Z
Heart Rhythm; 2016 May; 13(5):1088-1095. PubMed ID: 26776557
[TBL] [Abstract][Full Text] [Related]
2. Association of galectin-3 and fibrosis markers with long-term cardiovascular outcomes in patients with heart failure, left ventricular dysfunction, and dyssynchrony: insights from the CARE-HF (Cardiac Resynchronization in Heart Failure) trial.
Lopez-Andrès N; Rossignol P; Iraqi W; Fay R; Nuée J; Ghio S; Cleland JG; Zannad F; Lacolley P
Eur J Heart Fail; 2012 Jan; 14(1):74-81. PubMed ID: 22089058
[TBL] [Abstract][Full Text] [Related]
3. Cardiorenal status using amino-terminal pro-brain natriuretic peptide and cystatin C on cardiac resynchronization therapy outcomes: From the BIOCRT Study.
Truong QA; Szymonifka J; Januzzi JL; Contractor JH; Deaño RC; Chatterjee NA; Singh JP
Heart Rhythm; 2019 Jun; 16(6):928-935. PubMed ID: 30590191
[TBL] [Abstract][Full Text] [Related]
4. Effect of cardiac resynchronization therapy on broad neurohormone biomarkers in heart failure.
Dong YX; Burnett JC; Chen HH; Sandberg S; Yang YZ; Zhang Y; Chen PS; Cha YM
J Interv Card Electrophysiol; 2011 Apr; 30(3):241-9. PubMed ID: 21336616
[TBL] [Abstract][Full Text] [Related]
5. Myocardial fibrosis combined with NT-proBNP improves the accuracy of survival prediction in ADHF patients.
Yao Y; Feng L; Sun Y; Wang S; Sun J; Hu B
BMC Cardiovasc Disord; 2021 May; 21(1):264. PubMed ID: 34049488
[TBL] [Abstract][Full Text] [Related]
6. Longer right to left ventricular activation delay at cardiac resynchronization therapy implantation is associated with improved clinical outcome in left bundle branch block patients.
Kosztin A; Kutyifa V; Nagy VK; Geller L; Zima E; Molnar L; Szilagyi S; Ozcan EE; Szeplaki G; Merkely B
Europace; 2016 Apr; 18(4):550-9. PubMed ID: 26116830
[TBL] [Abstract][Full Text] [Related]
7. Prediction of clinical outcome in patients treated with cardiac resynchronization therapy - the role of NT-ProBNP and a combined response score.
Bakos Z; Chatterjee NC; Reitan C; Singh JP; Borgquist R
BMC Cardiovasc Disord; 2018 Apr; 18(1):70. PubMed ID: 29699498
[TBL] [Abstract][Full Text] [Related]
8. Clinical, echocardiographic, and neurohormonal response to cardiac resynchronization therapy: are they interchangeable?
Hoogslag GE; Höke U; Thijssen J; Auger D; Marsan NA; Wolterbeek R; Holman ER; Schalij MJ; Bax JJ; Verwey HF; Delgado V
Pacing Clin Electrophysiol; 2013 Nov; 36(11):1391-401. PubMed ID: 23826659
[TBL] [Abstract][Full Text] [Related]
9. Combination of left ventricular reverse remodeling and brain natriuretic peptide level at one year after cardiac resynchronization therapy predicts long-term clinical outcome.
Roubicek T; Stros J; Kucera P; Nedbal P; Cerny J; Polasek R; Wichterle D
PLoS One; 2019; 14(7):e0219966. PubMed ID: 31314790
[TBL] [Abstract][Full Text] [Related]
10. Coronary sinus biomarker sampling compared to peripheral venous blood for predicting outcomes in patients with severe heart failure undergoing cardiac resynchronization therapy: the BIOCRT study.
Truong QA; Januzzi JL; Szymonifka J; Thai WE; Wai B; Lavender Z; Sharma U; Sandoval RM; Grunau ZS; Basnet S; Babatunde A; Ajijola OA; Min JK; Singh JP
Heart Rhythm; 2014 Dec; 11(12):2167-75. PubMed ID: 25014756
[TBL] [Abstract][Full Text] [Related]
11. Differences in biomarkers in patients with heart failure with a reduced vs a preserved left ventricular ejection fraction.
de Denus S; Lavoie J; Ducharme A; O'Meara E; Racine N; Sirois MG; Neagoe PE; Zhu L; Rouleau JL; White M
Can J Cardiol; 2012; 28(1):62-8. PubMed ID: 22104539
[TBL] [Abstract][Full Text] [Related]
12. Improvement of serum NT-ProBNP predicts improvement in cardiac function and favorable prognosis after cardiac resynchronization therapy for heart failure.
Yu CM; Fung JW; Zhang Q; Chan CK; Chan I; Chan YS; Kong SL; Sanderson JE; Lam CW
J Card Fail; 2005 Jun; 11(5 Suppl):S42-6. PubMed ID: 15948100
[TBL] [Abstract][Full Text] [Related]
13. Mid-regional pro-atrial natriuretic peptide to predict clinical course in heart failure patients undergoing cardiac resynchronization therapy.
Arrigo M; Truong QA; Szymonifka J; Rivas-Lasarte M; Tolppanen H; Sadoune M; Gayat E; Cohen-Solal A; Ruschitzka F; Januzzi JL; Singh JP; Mebazaa A
Europace; 2017 Nov; 19(11):1848-1854. PubMed ID: 28096288
[TBL] [Abstract][Full Text] [Related]
14. Additional Diagnostic Value of Growth Differentiation Factor-15 (GDF-15) to N-Terminal B-Type Natriuretic Peptide (NT-proBNP) in Patients with Different Stages of Heart Failure.
Li J; Cui Y; Huang A; Li Q; Jia W; Liu K; Qi X
Med Sci Monit; 2018 Jul; 24():4992-4999. PubMed ID: 30019695
[TBL] [Abstract][Full Text] [Related]
15. Hyperuricemia predicts adverse clinical outcomes after cardiac resynchronization therapy.
Perge P; Boros AM; Zima E; Gellér L; Merkely B; Széplaki G
Scand Cardiovasc J; 2018 Oct; 52(5):250-255. PubMed ID: 30714413
[TBL] [Abstract][Full Text] [Related]
16. Collagen turnover biomarkers and systemic right ventricle remodeling in adults with previous atrial switch procedure for transposition of the great arteries.
Lipczyńska M; Szymański P; Kumor M; Klisiewicz A; Hoffman P
PLoS One; 2017; 12(8):e0180629. PubMed ID: 28767656
[TBL] [Abstract][Full Text] [Related]
17. Long-term statin therapy in patients with systolic heart failure and normal cholesterol: effects on elevated serum markers of collagen turnover, inflammation, and B-type natriuretic peptide.
Abulhul E; McDonald K; Martos R; Phelan D; Spiers JP; Hennessy M; Baugh J; Watson C; O'Loughlin C; Ledwidge M
Clin Ther; 2012 Jan; 34(1):91-100. PubMed ID: 22154198
[TBL] [Abstract][Full Text] [Related]
18. Low fibrosis biomarker levels predict cardiac resynchronization therapy response.
Massoullié G; Sapin V; Ploux S; Rossignol P; Mulliez A; Jean F; Marie PY; Merlin C; Pereira B; Andronache M; Motreff P; Chabin X; Sellal JM; Citron B; Lusson JR; Vorilhon C; Clerfond G; Bordachar P; Zannad F; Eschalier R
Sci Rep; 2019 Apr; 9(1):6103. PubMed ID: 30988339
[TBL] [Abstract][Full Text] [Related]
19. The relationship between serum markers of collagen turnover and cardiovascular outcome in the elderly: the Cardiovascular Health Study.
Barasch E; Gottdiener JS; Aurigemma G; Kitzman DW; Han J; Kop WJ; Tracy RP
Circ Heart Fail; 2011 Nov; 4(6):733-9. PubMed ID: 21900186
[TBL] [Abstract][Full Text] [Related]
20. N-terminal fragment of the prohormone brain-type natriuretic peptide (NT-proBNP), cardiovascular events, and mortality in patients with stable coronary heart disease.
Bibbins-Domingo K; Gupta R; Na B; Wu AH; Schiller NB; Whooley MA
JAMA; 2007 Jan; 297(2):169-76. PubMed ID: 17213400
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
